Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022)

Healthy Extracts' (HYEX) quarterly Capital Expenditures came in at $7987.0 in Q1 2022, down 65.25% quarter-over-quarter from $22985.0 in Q1 2019.

Healthy Extracts (HYEX) Capital Expenditures (2019 - 2022) Analysis & Trends

Healthy Extracts' Capital Expenditures history runs 2 years deep, the most recent figure standing at $7987.0 for Q1 2022.

On a quarterly basis, Capital Expenditures changed N/A year-over-year to $7987.0 in Q1 2022; TTM through Dec 2022 was $7987.0, a N/A change from a year earlier, with the FY2025 full-year figure at $19302.0, changed N/A from the prior year.
Capital Expenditures slipped to $7987.0 in Q1 2022 per HYEX's latest filing, from $22985.0 in the prior quarter.
Across five years, Capital Expenditures topped out at $22985.0 in Q1 2019 and bottomed at $7987.0 in Q1 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Capital Expenditures (Qtr)
1	Haleon	87.22 Bn	85.35 Bn	-	-
2	Teva Pharmaceutical Industries	39.60 Bn	35.87 Bn	1.97 Bn	168.00 Mn
3	Zoetis	31.46 Bn	29.52 Bn	1.62 Bn	110.00 Mn
4	Takeda Pharmaceutical	26.49 Bn	22.44 Bn	4.39 Bn	1.95 Bn
5	United Therapeutics	23.03 Bn	20.88 Bn	648.10 Mn	99.60 Mn
6	Universe Pharmaceuticals	23.03 Bn	-10.56 Bn	-	-
7	Viatris	20.90 Bn	19.09 Bn	1.16 Bn	39.90 Mn
8	Neurocrine Biosciences	17.50 Bn	16.19 Bn	800.70 Mn	1.40 Mn
9	Elanco Animal Health	12.33 Bn	11.91 Bn	785.00 Mn	51.00 Mn
10	Healthy Extracts	14.70 Mn	14.56 Mn	957,429.00	-

Download Data